Literature DB >> 22996832

The evolving practice of nuclear cardiology: results from the 2011 ASNC member survey.

Peter Tilkemeier1, Jacqueline Green, Andrew J Einstein, Reza Fazel, Patricia Reames, Leslee J Shaw.   

Abstract

BACKGROUND: Today's imaging laboratories face challenges including reimbursement, prior authorization, and accreditation standards. The impact on the practice of nuclear cardiology in the United States is unknown. We conducted a survey of ASNC members to provide a snapshot of nuclear cardiology imaging laboratories in 2011. METHODS AND
RESULTS: The survey identified practice patterns including personnel, volumes, protocols used, and laboratory characteristics. We employed random sampling methodology stratified geographically. The response rate was 19.5% (73/374 laboratories). A non-random survey conducted in 2001 of 25 laboratories served as a comparator. A total of 73 laboratories, representing 202 physicians and 177 technologists responded. The reported median procedural volume was 1,225 studies annually; 88.9% of laboratories were accredited. Compared with 2001, dual isotope imaging protocol use dropped from 72% to 15.6%. Five markers of quality were surveyed. Half of laboratories use the American College of Cardiology's Appropriate Use Criteria, 61% used segmental scoring, and 32% provided guidance on post-test therapeutic management. 89% perform catheterization correlations while only 33% implemented radiation dose tracking.
CONCLUSIONS: This survey of ASNC members provides critical information on nuclear cardiology practice to better target and service our members' needs. These data can prove invaluable to target educational needs and inform healthcare policy of contemporary nuclear cardiology practice.

Mesh:

Year:  2012        PMID: 22996832     DOI: 10.1007/s12350-012-9624-8

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  11 in total

1.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

2.  Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging.

Authors:  Robert C Hendel; Timothy M Bateman; Manuel D Cerqueira; Ami E Iskandrian; Jeffrey A Leppo; Brent Blackburn; John J Mahmarian
Journal:  J Am Coll Cardiol       Date:  2005-11-09       Impact factor: 24.094

3.  Radiation risk from coronary artery disease imaging: how do different diagnostic tests compare?

Authors:  Andrew J Einstein
Journal:  Heart       Date:  2008-12       Impact factor: 5.994

4.  The nuclear cardiology report: problems, predictors, and improvement. A report from the ICANL database.

Authors:  Peter L Tilkemeier; Eva R Serber; Mary Beth Farrell
Journal:  J Nucl Cardiol       Date:  2011-06-17       Impact factor: 5.952

5.  Radiation risk from cardiac CT and nuclear cardiology: addressing concerns with innovative solutions.

Authors:  Andrew J Einstein
Journal:  J Nucl Cardiol       Date:  2011-08       Impact factor: 5.952

6.  ACCF/AHA/HFSA 2011 survey results: current staffing profile of heart failure programs, including programs that perform heart transplant and mechanical circulatory support device implantation: a report of the ACCF Heart Failure and Transplant Committee, AHA Heart Failure and Transplantation Committee, and Heart Failure Society of America.

Authors:  Mariell Jessup; Nancy M Albert; David E Lanfear; Joann Lindenfeld; Barry M Massie; Mary Norine Walsh; Mark J Zucker
Journal:  J Am Coll Cardiol       Date:  2011-04-04       Impact factor: 24.094

7.  Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial.

Authors:  Ami E Iskandrian; Timothy M Bateman; Luiz Belardinelli; Brent Blackburn; Manuel D Cerqueira; Robert C Hendel; Hsiao Lieu; John J Mahmarian; Ann Olmsted; S Richard Underwood; João Vitola; Whedy Wang
Journal:  J Nucl Cardiol       Date:  2007 Sep-Oct       Impact factor: 5.952

8.  Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results.

Authors:  Manuel D Cerqueira; Patricia Nguyen; Peter Staehr; S Richard Underwood; Ami E Iskandrian
Journal:  JACC Cardiovasc Imaging       Date:  2008-05

9.  Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial (RegCOPD trial).

Authors:  Gregory S Thomas; Bruce R Tammelin; George L Schiffman; Rudy Marquez; Deborah L Rice; Douglas Milikien; Vandana Mathur
Journal:  J Nucl Cardiol       Date:  2008-04-14       Impact factor: 5.952

10.  The RegEx trial: a randomized, double-blind, placebo- and active-controlled pilot study combining regadenoson, a selective A(2A) adenosine agonist, with low-level exercise, in patients undergoing myocardial perfusion imaging.

Authors:  Gregory S Thomas; Randall C Thompson; Michael I Miyamoto; Tze K Ip; Deborah L Rice; Douglas Milikien; Hsiao D Lieu; Vandana S Mathur
Journal:  J Nucl Cardiol       Date:  2009-01-20       Impact factor: 5.952

View more
  5 in total

1.  Clinician-dependent variations in inappropriate use of myocardial perfusion imaging: training, specialty, and location.

Authors:  David E Winchester; Joseph Hymas; Ryan Meral; Daniel Nguyen; Raman Dusaj; Leslee J Shaw; Rebecca J Beyth
Journal:  J Nucl Cardiol       Date:  2014-03-27       Impact factor: 5.952

2.  Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease-state-of-the-evidence and clinical recommendations.

Authors:  Viviany R Taqueti; Sharmila Dorbala; David Wolinsky; Brian Abbott; Gary V Heller; Timothy M Bateman; Jennifer H Mieres; Lawrence M Phillips; Nanette K Wenger; Leslee J Shaw
Journal:  J Nucl Cardiol       Date:  2017-06-05       Impact factor: 5.952

Review 3.  Defining Quality in Cardiovascular Imaging: A Scientific Statement From the American Heart Association.

Authors:  Leslee J Shaw; Ron Blankstein; Jill E Jacobs; Jonathon A Leipsic; Raymond Y Kwong; Viviany R Taqueti; Rob S B Beanlands; Jennifer H Mieres; Scott D Flamm; Thomas C Gerber; John Spertus; Marcelo F Di Carli
Journal:  Circ Cardiovasc Imaging       Date:  2017-12       Impact factor: 7.792

4.  Nuclear cardiology practice and associated radiation doses in Europe: results of the IAEA Nuclear Cardiology Protocols Study (INCAPS) for the 27 European countries.

Authors:  Oliver Lindner; Thomas N B Pascual; Mathew Mercuri; Wanda Acampa; Wolfgang Burchert; Albert Flotats; Philipp A Kaufmann; Anastasia Kitsiou; Juhani Knuuti; S Richard Underwood; João V Vitola; John J Mahmarian; Ganesan Karthikeyan; Nathan Better; Madan M Rehani; Ravi Kashyap; Maurizio Dondi; Diana Paez; Andrew J Einstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-19       Impact factor: 9.236

5.  Use of myocardial perfusion imaging and estimation of associated radiation doses in Germany from 2005 to 2012.

Authors:  O Lindner; F M Bengel; M Hacker; W Schäfer; W Burchert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-12       Impact factor: 9.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.